Skip to main content

Table 3 The health-related quality of life by the EQ-5D (EuroQol) index and visual analogue scale (VAS) at six months after ICU admission compared to the age- and sex-matched general population

From: Six-month survival and quality of life of intensive care patients with acute kidney injury

  EQ-5D index EQ-5D VAS
  Study patients General population Study patients General population
All study patients (N = 959) 0.690 (0.533-1.00)a 0.845 (0.812-0.882) 73 (59–85) 70 (68–77)
No AKI patients (N = 632) 0.690 (0.533-1.00)a 0.845 (0.812-0.882) 75 (60–87) 70 (68–77)
AKI patients (N = 327) 0.676 (0.520-1.00)a 0.826 (0.812-0.859) 70 (50–83) 69 (68–73)
Stage 1 (N = 148) 0.691 (0.534-1.00)a 0.826 (0.812-0.876) 75 (60–86) 69 (68–76)
Stage 2 (N = 65) 0.631 (0.442-0.795)a 0.826 (0.774-0.859) 69 (50–82) 69 (65–73)
Stage 3 (N = 114) 0.676 (0.486-1.00)a 0.845 (0.826-0.859) 70 (50–80) 70 (68–73)
With RRT (of stage 3) (N = 85) 0.676 (0.482-0.802)a 0.845 (0.819-0.882) 65 (50–80)a 70 (68–77)
Without RRT (of stage 3) (N = 29) 0.676 (0.504-1.00) 0.826 (0.826-0.852) 70 (50–90) 68 (68–73)
  1. aP <0.001, comparison between the study patients and the age- and sex-matched general population.
  2. Values are presented as median (interquartile range, IQR). AKI, acute kidney injury (by the Kidney Disease Improving Global Outcomes, KDIGO criteria); RRT, renal replacement therapy.